Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Lonza
 More »

  • Teva Cutting 5,000 Jobs in Global Restructuring
    ... In July, Teva and Lonza Group ended a four-year-old joint venture to develop, manufacture, and market biosimilar drugs, hamstrung by slow progress toward approval standards in ...
    10-10-2013
  • Transfection Methods Evolving
    ... for maxGFP protein expression. [Lonza Pharma] "The challenge for transfection of ... Toell, Ph.D., senior product manager at Lonza Pharma & Biotech-Bioscience Solutions. ...
    9-1-2013
  • Biosimilar Marriage Ends in Divorce for Teva, Lonza
    and Lonza Group said today they would end their four-year-old joint venture to develop, manufacture, and market biosimilar drugs, four months after Lonza disclosed it was ...
    7-25-2013
  • Flexibility in Biopharmaceutical Manufacturing Capacity
    Single-use bioreactors are changing the biomolecular production landscape. Biologic drugs including monoclonal antibodies, therapeutic proteins, immunotherapies, and vaccines have ...
    5-28-2013
  • GEN | Biolinks
    ... Lixte Biotechnology Holdings, Inc Lonestar Heart, Inc Lonza (LCM) Louisana Economic Development Luitpold Pharmaceuticals, Inc. Lumigen -- a Wholly Owned Subsidiary pof Beckamn ...
  • Biosimilars: 10 Drugs to Watch
    ... and Lonza: End planned 544-patient, Phase III clinical trial of TLO11, saying they wanted input from regulators on designing the trial program (October 2012). On April 5, Lonza ...
    4-22-2013
  • Medicine: Getting Personal
    ... Kim Warren, head of development services for cell therapy at Lonza, commented on one of the challenges in moving the production of adherent cells to bioreactors and the use of ...
    3-15-2013
  • Biosimilars: Not So Far So Fast
    However, the company said, given the changes in the regulatory and competitive environment, "Teva (through its joint venture with Lonza) is evaluating the path forward for ...
    3-15-2013
  • Lonza and Hyglos Reach Agreement Settling Patent Dispute
    Lonza Walkersville and Hyglos signed an agreement that allows Hyglos to use recombinant ... The agreement also includes the dismissal of the lawsuit Lonza previously filed against ...
    3-14-2013
  • Electrophoretic Power Supply
    Lonza Muenchensteinerstrasse 38 SWITZERLAND CH-4002 Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and ...
    2-1-2013
  • Single-Use Systems Entice Multiple Users
    ... with standardization, which is why Lonza continues to fine tune its GS Gene ... GS Gene Expression is designed to work with the GS-CHO cell line, for which Lonza claims ...
    1-15-2013
  • Where Downstream Operations Are Headed
    II dosing range studies. "However, it is a very competitive marketplace, and Teva and Lonza have already halted their rituximab biosimilar development, so looking at areas such as ...
    1-1-2013
  • Sartorius Stedim Biotech Inks Cell Culture Deal with Lonza
    Sartorius Stedim Biotech (SSB) signed a cooperation agreement with Lonza covering cell ... therapeutics and vaccines, while Lonza will continue to carry out development, ...
    12-19-2012
  • Inventive Approaches Redefine Downstream Ops
    Lonza Biologics, for example, has developed a platform process for monoclonal antibody ... To alleviate a downstream bottleneck, the Lonza team adopted less compressible matrices ...
    12-1-2012
  • Optimizing Cell Lines Improves Production-Really!
    That was one of the main messages delivered at CHI's "Bioprocessing Summit", in the late summer. Jesús Zurdo, Ph.D., head of innovation for biopharma development at Lonza ...
    11-15-2012

  • Journal Articles

  • Optimization and Scale-up Culture of Human Endometrial Multipotent...
    Gayathri Rajaraman, Jacinta White, Ker Sin Tan, Daniela Ulrich, Anna Rosamilia, Jerome Werkmeister, Caroline E. Gargett
    Tissue Engineering, Part C: Methods
    greatest using a fibronectin matrix, with Lonza TP-SF® and our in-house DMEM/SF/FGF2/EGF ... CD146 and W5C5 compared to culture under similar conditions in Lonza TP-SF? medium. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll